ScreenerHero

BPTH Bio-Path Holdings, Inc.

Partial data
NAS · US · Healthcare · Biotechnology · biopathholdings.com
0.0002USD+100.00%Mkt Cap: 10059 $P/E: —

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platfo…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap10.06K USD
Enterprise Value529.06K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.89M USD
Revenue/Share—
Last Price0.0002 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.30
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-1.14
EPS (Forward)-4.04
52W Range
0.00010% of range0.1300
52W High0.1300 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-6424.68%
ROA-254.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.57M USD
CapEx (TTM)—
FCF Margin—
FCF Yield13742.67%
Net Debt518.00K USD
Net Debt/EBITDA-0.30
Balance Sheet
Debt/Equity0.54
Current Ratio0.00
Quick Ratio0.00
Book Value/Sh-0.19 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2019
Splits
Last Split1:20
Split DateFeb 23, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.50.30M
Float50.30M
Insiders0.00%
Institutions0.87%
Short Interest
Short Ratio0.4d
Short % Float1.38%
Short % Out.1.38%
Shares Short79.35K
Short (prev mo.)249.95K
Technical
SMA 500.0267 (-99.2%)
SMA 2000.0467 (-99.6%)
Beta-0.53
S&P 52W Chg15.96%
Avg Vol (30d)39.15K
Avg Vol (10d)22.37K
Technical Indicators
RSI (14)27.1
MACD-0.0083
MACD Signal-0.0053
MACD Hist.-0.0030
BB Upper0.0491 USD
BB Middle0.0232 USD
BB Lower-0.0027 USD
BB Width223.27%
ATR (14)0.0048 USD
Vol Ratio (20d)3.23x